SLGL (Sol-Gel Technologies) Cyclically Adjusted Revenue per Share: $5.76 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SLGL Sol-Gel Technologies Ltd SLGL
45 GF Score
Price $68.81
GF Value $5.96
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sol-Gel Technologies Cyclically Adjusted Revenue per Share?

Sol-Gel Technologies SLGL -5.18% 45 Cyclically Adjusted Revenue per Share is $5.76 as of Jun. 2026. GuruFocus rates SLGL with a GF Score™ of 45/100 and a GF Value™ of $5.96 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sol-Gel Technologies's adjusted revenue per share for the three months ended in Jun. 2026 was $0.181. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $5.76 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-30), Sol-Gel Technologies's current stock price is $68.81. Sol-Gel Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $5.76. Sol-Gel Technologies's Cyclically Adjusted PS Ratio of today is 11.95.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Sol-Gel Technologies was 15.28. The lowest was 11.94. And the median was 12.85.


Sol-Gel Technologies  (NAS:SLGL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sol-Gel Technologies's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=68.81/5.76
=11.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Sol-Gel Technologies was 15.28. The lowest was 11.94. And the median was 12.85.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sol-Gel Technologies Cyclically Adjusted Revenue per Share Related Terms


Sol-Gel Technologies Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Sol-Gel Technologies's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sol-Gel Technologies Cyclically Adjusted Revenue per Share Chart

Sol-Gel Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sol-Gel Technologies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 5.84 5.76

SLGL vs SABS, BCYC, CYDY: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Sol-Gel Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sol-Gel Technologies Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sol-Gel Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sol-Gel Technologies's Cyclically Adjusted PS Ratio falls into.


SLGL
45GF Score
Sol-Gel Technologies Ltd SLGL
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sol-Gel Technologies Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sol-Gel Technologies's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.181/333.9520*333.9520
=0.181

Current CPI (Jun. 2026) = 333.9520.

Sol-Gel Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 0.097 246.524 0.131
201803 0.030 249.554 0.040
201806 0.026 251.989 0.034
201809 0.020 252.439 0.026
201812 -0.001 251.233 -0.001
201903 3.355 254.202 4.408
201906 4.112 256.143 5.361
201909 2.392 256.759 3.111
201912 1.966 256.974 2.555
202003 1.622 258.115 2.099
202006 0.494 257.797 0.640
202009 0.920 260.280 1.180
202012 0.894 260.474 1.146
202103 0.305 264.877 0.385
202106 0.403 271.696 0.495
202109 3.731 274.310 4.542
202112 8.280 278.802 9.918
202203 0.001 287.504 0.001
202206 1.521 296.311 1.714
202209 0.113 296.808 0.127
202212 0.043 296.797 0.048
202303 0.120 301.836 0.133
202306 0.215 305.109 0.235
202309 0.077 307.789 0.084
202312 0.160 306.746 0.174
202403 0.167 312.332 0.179
202406 1.950 314.175 2.073
202409 1.924 315.301 2.038
202412 0.100 315.605 0.106
202503 0.370 319.799 0.386
202506 6.196 322.561 6.415
202509 0.144 324.800 0.148
202512 0.250 324.054 0.258
202603 0.038 330.213 0.038
202606 0.181 333.952 0.181

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $5.76 mean?
Sol-Gel Technologies (SLGL) has a Cyclically Adjusted Revenue per Share of $5.76 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sol-Gel Technologies and its competitors.
Is Sol-Gel Technologies' Cyclically Adjusted Revenue per Share too high?
Sol-Gel Technologies' current Cyclically Adjusted Revenue per Share is $5.76. Overall, Sol-Gel Technologies has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sol-Gel Technologies' Cyclically Adjusted Revenue per Share compare to SABS and BCYC?
Sol-Gel Technologies' Cyclically Adjusted Revenue per Share of $5.76 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sol-Gel Technologies and its competitors. Sol-Gel Technologies's current Cyclically Adjusted Revenue per Share is $5.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sol-Gel Technologies stock overvalued right now?
Based on GuruFocus' analysis, Sol-Gel Technologies (SLGL) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.96, compared to a current price of $68.81 — trading 1054.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $5.76. Sol-Gel Technologies' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Sol-Gel Technologies (SLGL), the current Cyclically Adjusted Revenue per Share is $5.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sol-Gel Technologies (SLGL) Overvalued in 2026?

Based on GuruFocus' analysis, Sol-Gel Technologies stock appears to be overvalued. The current stock price of $68.81 is trading 1054.5% above its estimated GF Value™ of $5.96. GuruFocus considers Sol-Gel Technologies to be Significantly Overvalued.

Key valuation signals for SLGL:

  • Cyclically Adjusted Revenue per Share: $5.76
  • GF Value™: $5.96 vs. price of $68.81 (1054.5% above fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the SLGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sol-Gel Technologies Business Description

Other Exchanges 4SG:Germany
Address 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
45GF Score

Get the complete analysis for SLGL

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.81
Price
$5.96
GF Value